Search Results - Daniel D. Von Hoff

Daniel Von Hoff

Daniel D. Von Hoff Daniel D. Von Hoff is the physician in chief and director of translational research at Translational Genomics Research Institute (TGen), and current Virginia G. Piper Distinguished Chair for Innovative Cancer Research at HonorHealth Clinical Research Institute. He is also a professor of medicine at the Mayo Clinic and medical director of research as well as chief scientific officer at US Oncology. He is most notable for his work in targeted therapies for the treatment of cancer. He led the development of gemcitabine, and has several drugs in development. Provided by Wikipedia
  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Telomerase Assay Using Biotinylated-Primer Extension and Magnetic Separation of the Products by Daekyu Sun, Laurence H. Hurley, Daniel D. Von Hoff

    Published in BioTechniques (1998-12-01)
    Get full text
    Article


  2. 2

    Blocking Nerve Growth Factor Signaling Reduces the Neural Invasion Potential of Pancreatic Cancer Cells. by Aditi A Bapat, Ruben M Munoz, Daniel D Von Hoff, Haiyong Han

    Published in PLoS ONE (2016-01-01)
    Get full text
    Article


  3. 3

    Magnetic resonance imaging of tumor response to stroma-modifying pegvorhyaluronidase alpha (PEGPH20) therapy in early-phase clinical trials by Andrés M. Arias-Lorza, James R. Costello, Sunil R. Hingorani, Daniel D. Von Hoff, Ronald L. Korn, Natarajan Raghunand

    Published in Scientific Reports (2024-05-01)
    Get full text
    Article


  4. 4

    Can Imaging Using Radiomics and Fat Fraction Analysis Detect Early Tissue Changes on Historical CT Scans in the Regions of the Pancreas Gland That Subsequently Develop Adenocarcino... by Ronald Lee Korn, Andre Burkett, Jeff Geschwind, Dominic Zygadlo, Taylor Brodie, Derek Cridebring, Daniel D. Von Hoff, Michael J. Demeure

    Published in Diagnostics (2023-03-01)
    Get full text
    Article


  5. 5

    Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells. by Caroline H Diep, Kelly M Zucker, Galen Hostetter, Aprill Watanabe, Chengcheng Hu, Ruben M Munoz, Daniel D Von Hoff, Haiyong Han

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  6. 6

    Advanced glycation end product (AGE) targeting antibody SIWA318H is efficacious in preclinical models for pancreatic cancer by Gabriela R. Rossi, Ashley Jensen, Serina Ng, Zhirong Yin, Aimin Li, Anjan Misra, Daniel D. Von Hoff, Lewis Gruber, Misty Gruber, Haiyong Han

    Published in Scientific Reports (2023-10-01)
    Get full text
    Article


  7. 7

    Phase II clinical trial of nab‐paclitaxel plus cisplatin plus gemcitabine (NABPLAGEM) in patients with untreated advanced pancreatic cancer by Gayle S. Jameson, Peter J. Hosein, Erin Pierce, Mandana Kamgar, Michael S. Gordon, Courtney Snyder, Denise J. Roe, Betsy C. Wertheim, Marina Davey, Michael T. Barrett, Daniel D. Von Hoff, Erkut Borazanci

    Published in Cancer Medicine (2024-06-01)
    Get full text
    Article


  8. 8

    Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions by Wei Lin, Pawan Noel, Erkut H. Borazanci, Jeeyun Lee, Albert Amini, In Woong Han, Jin Seok Heo, Gayle S. Jameson, Cory Fraser, Margaux Steinbach, Yanghee Woo, Yuman Fong, Derek Cridebring, Daniel D. Von Hoff, Joon Oh Park, Haiyong Han

    Published in Genome Medicine (2020-09-01)
    Get full text
    Article


  9. 9

    Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma. by Glen J Weiss, Winnie S Liang, Tyler Izatt, Shilpi Arora, Irene Cherni, Robert N Raju, Galen Hostetter, Ahmet Kurdoglu, Alexis Christoforides, Shripad Sinari, Angela S Baker, Raghu Metpally, Waibhav D Tembe, Lori Phillips, Daniel D Von Hoff, David W Craig, John D Carpten

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  10. 10

    Inhibiting stromal Class I HDACs curbs pancreatic cancer progression by Gaoyang Liang, Tae Gyu Oh, Nasun Hah, Hervé Tiriac, Yu Shi, Morgan L. Truitt, Corina E. Antal, Annette R. Atkins, Yuwenbin Li, Cory Fraser, Serina Ng, Antonio F. M. Pinto, Dylan C. Nelson, Gabriela Estepa, Senada Bashi, Ester Banayo, Yang Dai, Christopher Liddle, Ruth T. Yu, Tony Hunter, Dannielle D. Engle, Haiyong Han, Daniel D. Von Hoff, Michael Downes, Ronald M. Evans

    Published in Nature Communications (2023-12-01)
    Get full text
    Article


  11. 11

    A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer by Corina E. Antal, Tae Gyu Oh, Stefan Aigner, En-Ching Luo, Brian A. Yee, Tania Campos, Hervé Tiriac, Katherine L. Rothamel, Zhang Cheng, Henry Jiao, Allen Wang, Nasun Hah, Elizabeth Lenkiewicz, Jan C. Lumibao, Morgan L. Truitt, Gabriela Estepa, Ester Banayo, Senada Bashi, Edgar Esparza, Ruben M. Munoz, Jolene K. Diedrich, Nicole M. Sodir, Jasmine R. Mueller, Cory R. Fraser, Erkut Borazanci, David Propper, Daniel D. Von Hoff, Christopher Liddle, Ruth T. Yu, Annette R. Atkins, Haiyong Han, Andrew M. Lowy, Michael T. Barrett, Dannielle D. Engle, Gerard I. Evan, Gene W. Yeo, Michael Downes, Ronald M. Evans

    Published in Nature Communications (2023-09-01)
    Get full text
    Article


Search Tools: